Evaluation of the Fibromyalgia and Related Risk Factors in Patients with Advanced Kidney Failure Undergoing Hemodialysis | Bentham Science
Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Evaluation of the Fibromyalgia and Related Risk Factors in Patients with Advanced Kidney Failure Undergoing Hemodialysis

Author(s): Seyed Mostafa Seyedmardani*, Saeed Abkhiz, Azadeh Megrazi, Aarefeh Jafarzade and Golshan Kamali Zonouz

Volume 18, Issue 1, 2022

Published on: 21 October, 2021

Page: [33 - 38] Pages: 6

DOI: 10.2174/1573397117666211021170438

Price: $65

Open Access Journals Promotions 2
Abstract

Background: Fibromyalgia syndrome (FMS) is defined as widespread and persistent pain in the musculoskeletal system. There are limited reports regarding the prevalence of fibromyalgia syndrome in patients with advanced kidney failure undergoing regular hemodialysis. Therefore, this study aimed to evaluate the prevalence of fibromyalgia syndrome and its risk factors in a large proportion of patients under the hemodialysis condition.

Materials and Methods: In this cross-sectional study, 293 patients who were admitted to the hemodialysis ward were evaluated for fibromyalgia syndrome in an educational hospital. The questionnaire was designed according to symptom severity score (SS score) and widespread pain index (WPI) criteria. The correlation between FMS and various variables, including demographic, clinical, and biochemistry biomarkers, was also precisely calculated by logistic regression. Data were analyzed using SPSS v.17 statistics software.

Results: The results showed that, of 293 hemodialysis patients, 130 patients (44.4%) had fibromyalgia, the mean age of patients with and without fibromyalgia was 61.09 ± 15.36 and 53.49 ± 15.38 years old, respectively (P = 0.001). Moreover, there was a significant difference in terms of gender among patients with fibromyalgia syndrome (P = 0.001). To note, there was no significant relationship between the kidney failure etiopathogenesis, duration of dialysis, body mass index (BMI), Kt/v index, history of peritoneal dialysis, and laboratory parameters with fibromyalgia in hemodialysis patients (P > 0.05). However, our findings revealed that both age and gender could be considered as the predictor variables associated with fibromyalgia in patients undergoing hemodialysis.

Conclusion: Taken together, in this study, we found that age and gender would be the critical factors in terms of the fibromyalgia syndrome in patients undergoing hemodialysis.

Keywords: Fibromyalgia syndrome, hemodialysis, risk factors, kidney failure, rheumatologic disorders, hemodialysis.

« Previous Next »
[1]
Clauw DJ. Fibromyalgia: a clinical review. JAMA 2014; 311(15): 1547-55.
[http://dx.doi.org/10.1001/jama.2014.3266] [PMID: 24737367]
[2]
Wolfe F, Smythe HA, Yunus MB, et al. Criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33(2): 160-72.
[http://dx.doi.org/10.1002/art.1780330203] [PMID: 2306288]
[3]
Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292(19): 2388-95.
[http://dx.doi.org/10.1001/jama.292.19.2388] [PMID: 15547167]
[4]
Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F. The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PLoS One 2015; 10(9): e0138024.
[http://dx.doi.org/10.1371/journal.pone.0138024] [PMID: 26379048]
[5]
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38(1): 19-28.
[http://dx.doi.org/10.1002/art.1780380104] [PMID: 7818567]
[6]
Ruiz-Pérez I, Plazaola-Castaño J, Cáliz-Cáliz R, et al. Risk factors for fibromyalgia: the role of violence against women. Clin Rheumatol 2009; 28(7): 777-86.
[http://dx.doi.org/10.1007/s10067-009-1147-6] [PMID: 19277813]
[7]
Hawkins RA. Fibromyalgia: a clinical update. J Am Osteopath Assoc 2013; 113(9): 680-9.
[PMID: 24005088]
[8]
Crofford LJ, Demitrack MA. Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am 1996; 22(2): 267-84.
[http://dx.doi.org/10.1016/S0889-857X(05)70272-6] [PMID: 8860799]
[9]
Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain research and treatment. 2012; 2012
[http://dx.doi.org/10.1155/2012/426130]
[10]
Sarzi-Puttini P, Atzeni F, Masala IF, Salaffi F, Chapman J, Choy E. Are the ACR 2010 diagnostic criteria for fibromyalgia better than the 1990 criteria? Autoimmun Rev 2018; 17(1): 33-5.
[http://dx.doi.org/10.1016/j.autrev.2017.11.007] [PMID: 29108831]
[11]
Ferrari R. Rheumatologic manifestations of renal disease. Curr Opin Rheumatol 1996; 8(1): 71-6.
[http://dx.doi.org/10.1097/00002281-199601000-00013] [PMID: 8867543]
[12]
de Groot K. Renal manifestations in rheumatic diseases. Internist (Berl) 2007; 48(8): 779-85.
[http://dx.doi.org/10.1007/s00108-007-1887-9] [PMID: 17571244]
[13]
Yücel AE, Kart-Köseoglu H, Isiklar I, Kuruinci E, Özdemir FN, Arslan H. Bone mineral density in patients on maintenance hemodialysis and effect of chronic hepatitis C virus infection. Ren Fail 2004; 26(2): 159-64.
[http://dx.doi.org/10.1081/JDI-120038501] [PMID: 15287200]
[14]
Kart-Köseoglu H, Yucel AE, Niron EA, Köseoglu H, Isiklar I, Ozdemir FN. Osteoarthritis in hemodialysis patients: relationships with bone mineral density and other clinical and laboratory parameters. Rheumatol Int 2005; 25(4): 270-5.
[http://dx.doi.org/10.1007/s00296-003-0431-z] [PMID: 14999425]
[15]
Couto CI, Natour J, Carvalho AB. Fibromyalgia: its prevalence and impact on the quality of life on a hemodialyzed population. Hemodial Int 2008; 12(1): 66-72.
[http://dx.doi.org/10.1111/j.1542-4758.2008.00243.x] [PMID: 18271844]
[16]
Haroon MM, Sayed S, Al-ghitany A, Ezzat H, Gheita T. Rheumatic and musculoskeletal manifestations in renal hemodialysis patients. Int J Clin Rheumatol 2018; 13(5): 263-9.
[http://dx.doi.org/10.4172/1758-42721000196]
[17]
Yuceturk TE, Yucel AE, Yuceturk H, et al. Fibromyalgia: its prevalence in haemodialysis patients and its relationships with clinical and laboratory parameters. Nephrol Dial Transplant 2005; 20(11): 2485-8.
[http://dx.doi.org/10.1093/ndt/gfi028] [PMID: 16046505]
[18]
Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int 2017; 37(9): 1527-39.
[http://dx.doi.org/10.1007/s00296-017-3725-2] [PMID: 28447207]
[19]
Ozelsancak R, Doruk Analan P, Leblebici B. Factors Associated with Fibromyalgia Syndrome in Peritoneal Dialysis Patients. Physiother Can 2019; 71(1): 77-81.
[http://dx.doi.org/10.3138/ptc.2017-45.ep] [PMID: 30787502]
[20]
Smith SB, Maixner DW, Fillingim RB, et al. Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum 2012; 64(2): 584-93.
[http://dx.doi.org/10.1002/art.33338] [PMID: 21905019]
[21]
Whipple MO, McAllister SJ, Oh TH, Luedtke CA, Toussaint LL, Vincent A. Construction of a US fibromyalgia registry using the Fibromyalgia Research Survey criteria. Clin Transl Sci 2013; 6(5): 398-9.
[http://dx.doi.org/10.1111/cts.12056] [PMID: 24127929]
[22]
Ceko M, Bushnell MC, Gracely RH. Neurobiology underlying fibromyalgia symptoms. Pain Res Treat 2012; 2012: 585419.
[http://dx.doi.org/10.1155/2012/585419] [PMID: 22135739]
[23]
Häuser W, Galek A, Erbslöh-Möller B, et al. Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome. Pain 2013; 154(8): 1216-23.
[http://dx.doi.org/10.1016/j.pain.2013.03.034] [PMID: 23685006]
[24]
Sievers DP. Marcus. Fibromyalgia-symptom or diagnosis: a definition of the position. Scand J Rheumatol 2000; 29(113): 3-7.
[http://dx.doi.org/10.1080/030097400446553]
[25]
Senmar M, Zarabadi Pour F, Soleimani P, Amini M, Rafiei H. The prevalence of musculoskeletal disorders among nurses working in emergency department. J Prev Epidemiol 2019; 4(2): e12.
[26]
Almod VR, Carmona L, Zarco P, Collantes E, Mulero J, Fernandez SJ. Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol-Incl Suppl 2010; 28(6): S33.

Rights & Permissions Print Cite
Article Metrics
37
3
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy